Extension Study of ABBV-8E12 in Patients With Progressive Supranuclear Palsy (PSP) Who Completed Study C2N-8E12-WW-104

Clinical trial NCT03413319 · COMPLETED

Trial details

NCT number: NCT03413319
Sponsor: AbbVie
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Progressive Supranuclear Palsy (PSP)

Start date: 2018-04-17
Primary completion: 2019-11-20
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.